Assessment of the Safety and Efficacy Study of RGN-259 Ophthalmic Solutions for Neurotrophic Keratopathy : SEER-1
Clinical trial NCT02600429 · TERMINATED
Trial details
- NCT number
- NCT02600429
- Sponsor
- ReGenTree, LLC
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-09-17
- Primary completion
- 2019-11-20
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.